Furthermore, the PNPLA3 genotype seems to also influence steatosis development in patients with hepatitis B and hepatitis C and alcohol abuse, and it has been independently associated with the progression of hepatitis, including fibrosis, cirrhosis, and HCC occurrence [134–136]. This evidence concerns the gene PNPLA3 and hepatocellular carcinoma.